Prevention of epilepsy;Prevención de la epilepsia

Revista de Neurologia

Volumn 34, Issue 2, 2002, Pages 186-195

  Legido, A ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Anticonvulsivants; Antiepileptic drugs; Antiepileptogenesis; Convulsions; Epilepsy; Neuroprotection; Prevention; Prophylaxis

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ANTICONVULSIVE AGENT; ANTIOXIDANT; APTIGANEL; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DIAZEPAM; DIZOCILPINE; ELIPRODIL; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; GAVESTINEL; KAPPA OPIATE RECEPTOR ANTAGONIST; LAMOTRIGINE; LUBELUZOLE; MELATONIN; NEUROPROTECTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; S NITROSOGLUTATHIONE; SIPATRIGINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ALTERNATIVE MEDICINE; CONFERENCE PAPER; DRUG RESEARCH; EPILEPSY; EPILEPTIC FOCUS; EPILEPTOGENESIS; GENE THERAPY; HUMAN; NEUROPROTECTION; PROPHYLAXIS; VACCINATION;

EID: 17344385244     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3402.2001354     Document Type: Conference Paper

References (80)

1. Prophylactic treatment
2. Epidemiology of epilepsy in children
3. The epidemiology of epilepsy
4. Sudden unexpected death in epilepsy: A series of witnessed deaths
5. Assessing risk to benefit ratio in antiepileptic drug therapy
6. Remission, intractability, mortality, and comorbidity of seizures
7. Estimating the costs of epilepsy: An international comparison of epilepsy cost studies
8. The costs of childhood epilepsy in Italy: Comparative findings in three health care settings
9. Prevention as it pertains to epilepsy
10. Critical review of health care for epilepsy
11. Postnatal epilepsy following EEG confirmed neonatal seizures
12. New waves of research in the epilepsies: Crossing into the third millennium
13. Perinatal hypoxic-ischemic encephalopathy: Current and future treatments
14. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest
15. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycemia
16. Pyridoxine-dependent and pyridoxine-responsive seizures
17. Encefalitis virales
18. Effect of the mandatory helmet law in Taiwan
19. Motor vehicle crash injury patterns and the Virginia seat belt law
20. Epidemiology and prevention of traffic injuries to urban children and adolescents
21. Prevention of a first stroke: Review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
22. A controlled trial of diazepam administered during febrile illness to prevent recurrence of febrile seizures
23. Preventive treatment for recurrent febrile seizures
24. Seizure precipitants and perceived self-control of seizures in adults with poorly-controlled epilepsy
25. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs
26. Antiepileptogenic agents. How close are we?
27. Animal models of intractable epilepsy
28. Effects of valproate, phenytoin, and MK-801 in a novel model of epileptogenesis
29. Effects of procaine hydrochloride, diazepam and diphenylhydantoin on seizure development in cortical and subcortical structures in rat
30. Inhibition or enhancement of Kindling evolution by antiepileptics
31. Antiepileptogenesic effects of conventional anticonvulsants in the Kindling model of epilepsy
32. Prophylactic effects of phenytoin, phenobarbital and carbamazepine examined in Kindling cat preparations
33. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Four-month follow-up period: Seizure, EEG, blood, and behavioral data
34. Postraumatic epilepsy
35. Traitements antiépileptiques dans les lésions cérébrales: Quelles sont les indications et les principales attitudes pratiques?
36. Pharmacological prophylaxis of post-traumatic epilepsy
37. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury
38. A randomized, doulbe-blind study of phenytoin for the prevention of post-traumatic seizures
39. Practice parameter: Antiepileptic drug treatment of postraumatic seizures
40. Stroke-related epilepsy
41. Vascular causes of epilepsy. Overview
42. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 198-1989 and 1990-1998
43. Postoperative anticonvulsant prophylaxis for patients treated for cerebral aneurysms
44. Radiosurgery for epilepsy associated with cavernous malformation: Retrospective study in 49 patients
45. Brain tumors and epilepsy
46. Febrile seizures
47. Treatment of children with simple febrile seizures. The AAP practice parameter
48. Risk factors for absence seizures: A population-based case-control study in Rochester, Minnesota
49. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure
50. Initiation and discontinuation of antiepileptic drugs
51. Epileptic seizures in an Andean region of Ecuador: Prevalence and incidence and regional variation
52. Early development of intractable epilepsy in children. A prospective study
53. A point mutation (D79N) of the alpha 2A receptor abolishes the antiepileptogenic action of endogenous norepinephrine
54. Ontogenesis and treatment efficacy: Prevention of seizures in the immature brain
55. Neuroprotection and epilepsy
56. Perinatal hypoxic-ischemic encephalopathy: Current advances in diagnosis and treatment
57. Pathophysiology of perinatal hypoxic-ischemic encephalopathy
58. Acute hypoxia induced alterations of calbindin-D28k in Purkinje cells and subcellular fractions of fetal Guinea pig cerebellum at term
59. How does trauma cause epilepsy?
60. Posttraumatic epilepsy prevention
61. Tratamiento de la epilepsia por estimulación vagal
62. Vagus nerve stimulation in pediatric patients with intractable epilepsy: Case series and operative technique
63. Surgery for intractable infantile spasms: Neuroimaging perspectives
64. Seizure outcome after epilepsy surgery in children and adolescents
65. Epilepsy surgery in the first three years of life
66. Predictors of outcome in pediatric epilepsy surgery
67. Epilepsy surgery in infants and children
68. Mesial temporal lobe epilepsy: What have we learned?
69. Regulation of gene expression by herbal medicines. A new paradigm of gene therapy for multifocal abnormalities of genes
70. Psychological approaches to the prevention and inhibition of nocturnal epileptic seizures: A meta-analysis of 70 case studies
71. An automated system for focal epilepsy
72. Nonlinear EEG analysis and its potential role in epileptology
73. Identification of genetic defect of an epilepsy: Strategies for therapeutic advances
74. Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: Implications for a gene therapy approach to epilepsy
75. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy
76. Sparing of neuronal function postseizure with gene therapy
77. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy